# Innate Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/innate-pharma-s-a

- Industry: Pharmaceuticals
- Headquarters: Marseille, France
- Website: www.innate-pharma.com
- Total disclosed funding: $38M
- Latest round: Series C (Oct 9, 2004)
- Investors on record: 10

## About

Innate Pharma S.A. is a biopharmaceutical company developing immunotherapy drugs for cancer and inflammatory diseases.

## Funding rounds

- Series C, Oct 9, 2004, $19M — Alta Partners, Auriga Partners, Ardian, Sofinnova Partners, Gimv, Daiwa Corporate Investment, Quilvest Capital Partners, Novo Nordisk A/S, Gilde Biotech & Nutrition
- Series B, Jul 8, 2002, $20M — Alta Partners, Auriga Partners, Ardian, Sofinnova Partners, Gimv, Pechel Industries, Gilde Biotech & Nutrition

## Investors

- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series B, Series C
- Auriga Partners (https://capitalatlas.ai/funds/auriga-partners) — Series B, Series C
- Ardian (https://capitalatlas.ai/funds/ardian) — Series B, Series C
- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series B, Series C
- Gimv (https://capitalatlas.ai/funds/gimv) — Series B, Series C
- Pechel Industries (https://capitalatlas.ai/funds/pechel-industries) — Series B
- Gilde Biotech & Nutrition — Series B, Series C
- Daiwa Corporate Investment (https://capitalatlas.ai/funds/daiwa-corporate-investment) — Series C
- Quilvest Capital Partners (https://capitalatlas.ai/funds/quilvest-capital-partners) — Series C
- Novo Nordisk A/S — Series C